Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
2011 1
2012 1
2013 2
2014 2
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Inborn glycerol kinase deficiency"
Page 1
Pseudo-hypertriglyceridaemia or hyperglycerolemia?
Arrobas-Velilla T, Mondéjar-García R, Gómez-Gerique JA, Cañizares Díaz I, Cruz Mengibar MC, Orive de Diego A, Fabiani-Romero F. Arrobas-Velilla T, et al. Clin Investig Arterioscler. 2013 Jul-Aug;25(3):123-6. doi: 10.1016/j.arteri.2013.05.005. Epub 2013 Jul 19. Clin Investig Arterioscler. 2013. PMID: 23877006
Hyperglycerolemia is a very rare genetic disorder caused by glycerol kinase deficiency. ...
Hyperglycerolemia is a very rare genetic disorder caused by glycerol kinase deficiency. ...
Adrenal dysfunction in glycerol kinase deficiency.
Seltzer WK, Firminger H, Klein J, Pike A, Fennessey P, McCabe ER. Seltzer WK, et al. Biochem Med. 1985 Apr;33(2):189-99. doi: 10.1016/0006-2944(85)90027-4. Biochem Med. 1985. PMID: 2988520 Review.
The infantile form of glycerol kinase deficiency appears to be an X-linked disorder which is consistently characterized by developmental delay and adrenal cortical insufficiency and hypoplasia. ...
The infantile form of glycerol kinase deficiency appears to be an X-linked disorder which is consistently characterized …
Cholestasis and Hepatic Iron Deposition in an Infant With Complex Glycerol Kinase Deficiency.
Montoya-Williams D, Mowitz M. Montoya-Williams D, et al. Pediatrics. 2017 Jul;140(1):e20161479. doi: 10.1542/peds.2016-1479. Pediatrics. 2017. PMID: 28759390
We present a 6-week-old male infant with persistent hyperbilirubinemia, hypertriglyceridemia, elevated creatine kinase levels, and transaminitis since the second week of life. When he developed hyperkalemia, clinical suspicion was raised for adrenal insufficiency despite h …
We present a 6-week-old male infant with persistent hyperbilirubinemia, hypertriglyceridemia, elevated creatine kinase levels, and transamin …
Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia.
Kramer CK, Borgoño CA, Van Nostrand P, Retnakaran R, Zinman B. Kramer CK, et al. Diabetes Care. 2014 Apr;37(4):1076-82. doi: 10.2337/dc13-2339. Epub 2013 Nov 15. Diabetes Care. 2014. PMID: 24241790
RESEARCH DESIGN AND METHODS Ten adults with T1D (mean age 56.6 9.0 years, duration of diabetes 26.4 7.5 years, HbA1c 7.5% 0.77, and BMI 24.1 kg/m(2) [22.6-25.4]) underwent 3-h 50-g oral glucose tolerance tests (OGTTs) on two separate days at least 24 h apart in random orde …
RESEARCH DESIGN AND METHODS Ten adults with T1D (mean age 56.6 9.0 years, duration of diabetes 26.4 7.5 years, HbA1c 7.5% 0.77, and BMI 24.1 …
Vitamin D, insulin secretion, sensitivity, and lipids: results from a case-control study and a randomized controlled trial using hyperglycemic clamp technique.
Grimnes G, Figenschau Y, Almås B, Jorde R. Grimnes G, et al. Diabetes. 2011 Nov;60(11):2748-57. doi: 10.2337/db11-0650. Epub 2011 Sep 12. Diabetes. 2011. PMID: 21911741 Free PMC article. Clinical Trial.
A 3-h hyperglycemic clamp was performed, and the participants with low serum 25(OH)D levels were thereafter randomized to receive capsules of 20,000 IU vitamin D(3) or identical-looking placebo twice weekly for 6 months. ...After supplementation, serum 25(OH)D was 142.7 25 …
A 3-h hyperglycemic clamp was performed, and the participants with low serum 25(OH)D levels were thereafter randomized to receive cap …
Using high-dose omega-3 fatty acid supplements to lower triglyceride levels in 10- to 19-year-olds.
de Ferranti SD, Milliren CE, Denhoff ER, Steltz SK, Selamet Tierney ES, Feldman HA, Osganian SK. de Ferranti SD, et al. Clin Pediatr (Phila). 2014 May;53(5):428-38. doi: 10.1177/0009922814528032. Clin Pediatr (Phila). 2014. PMID: 24707021 Free PMC article. Clinical Trial.
METHODS: Twenty-five patients aged 10 to 19 years with TG levels 150 to 1000 mg/dL were randomized to 6 months double-blind trial of Lovaza (~3360 mg docosahexaenoic acid + eicosapentaenoic acid per day) versus placebo. ...
METHODS: Twenty-five patients aged 10 to 19 years with TG levels 150 to 1000 mg/dL were randomized to 6 months double-blind trial …
The whey fermentation product malleable protein matrix decreases TAG concentrations in patients with the metabolic syndrome: a randomised placebo-controlled trial.
Gouni-Berthold I, Schulte DM, Krone W, Lapointe JF, Lemieux P, Predel HG, Berthold HK. Gouni-Berthold I, et al. Br J Nutr. 2012 Jun;107(11):1694-706. doi: 10.1017/S0007114511004843. Br J Nutr. 2012. PMID: 21996130 Clinical Trial.
Animal and human studies suggest that a malleable protein matrix (MPM) from whey decreases plasma lipid concentrations and may positively influence other components of the metabolic syndrome such as glucose metabolism and blood pressure (BP). The primary objective of this double- …
Animal and human studies suggest that a malleable protein matrix (MPM) from whey decreases plasma lipid concentrations and may positively in …